Share
 
Title
Code
Session Type
Channel
Date Time
Co-Chairs:
17:30
OA09.01
BCG.HTI2auxo.int priming vaccination enhances the HIV-1 specific T cell immune responses elicited by MVA.HTI
Narcís Saubi, Vall d'Hebron Institut de Recerca, Spain
17:38
OA09.02
Anti-Env antibody-independent protection of repeated intrarectal low-dose SIVmac239 challenges in rhesus macaques by vaccination inducing Gag/Vif-specific CD8+ T but not CD4+ T cells
Hiroshi Ishii, National Institute of Infectious Diseases, Japan
17:46
OA09.03
Impact of HLA-II associated HIV-1 adaptations on vaccine-induced CD4 T-cell immune responses
Jacob Files, University of Alabama at Birmingham, United States
17:54
OA09.04
Applying insights from HIV to guide the development of a T cell vaccine for SARS-CoV-2
Anusha Nathan, Ragon Institute of MGH, MIT, and Harvard, United States
18:02
OA09.05LB
Spontaneous in vivo control of HIV replication is underpinned by the cross-clade antiviral potency of HIV-specific CD8 T cells
Julia Makinde, Imperial College London, United Kingdom
18:10
OA09.06
Live Q&A